Chronic Rhinosinusitis with Nasal Polyps: Latest Trends in Diagnosis and Treatment
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Surgery".
Deadline for manuscript submissions: 20 May 2026 | Viewed by 1737
Special Issue Editors
Interests: ENT; rhinology; CRSwNP; biologics; head & neck; otology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With a focus on CRSwNP, this Special Issue proposal discusses crucial aspects of diagnosis, multidisciplinary care, and therapy developments. The goal of this issue is to give a thorough review of the most cutting-edge methods and best practices currently used in clinical practice.
CRSwNP, like other chronic diseases, has a negative impact on the quality of life, and for years there have been serious management problems due to the difficulty of control using only the therapeutic options available until recently. In some cases, despite the high use of systemic corticosteroids and surgical interventions, the patient does not in fact achieve adequate control of their symptoms or a sufficient quality of life. In recent years, however, new therapeutic options have opened up for these patients, thanks to new biological drugs capable of suppressing naso-sinus inflammation, selectively blocking key cytokines of the typical inflammatory mechanisms associated with CRSwNP. We also aim to explore how important it is for multidisciplinary teams to work together to optimize treatment plans and enhance patient care. Case studies and expert perspectives will be used to analyze this collaborative approach, presenting effective examples of interdisciplinary teamwork with allergologists, radiologists, immunologists, and pneumologists.
To correctly classify patients with CRSwNP, a pathology in most cases is supported by eosinophilic inflammation, a solid phenotyping ability, and an integrated multidisciplinary approach, which can allow for both timely diagnosis and selection of the most correct treatment path for all patients. Thus, in conjunction with the advent of new biological therapies indicated for CRSwNP, to promote their most appropriate and integrated application with the "standard of care", it is necessary to build a theoretical–practical training path to develop knowledge and skills around the new evidence and management of this pathology.
Dr. Bruno Galletti
Guest Editor
Dr. Cosimo Galletti
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic rhinosinusitis with nasal polyps
- real-word evidence
- otorhinolaryngology
- rhinology, quality of life, therapeutic advances
- monoclonal antibodies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
